4/A: Cardio Diagnostics Holdings Officer Timur Dogan Reports Stock Purchase

Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, reports the acquisition of 68,965 shares of common stock at $0.29 per share.

Summary

• On September 6, 2024, Timur Dogan, the Chief Technology Officer of Cardio Diagnostics Holdings, acquired 68,965 shares of common stock at a price of $0.29 per share.
• The transaction was reported on September 23, 2024, as an amendment to a previous filing on September 9, 2024.
• Following the transaction, Dogan directly owns 128,345 shares individually and 68,965 shares jointly with his spouse, the CEO, totaling 197,310 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An insider purchase is generally a good sign, but the scale of the purchase is relatively small.

Positives

• The purchase of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's performance and future expectations. This purchase by the CTO could be interpreted as a positive sign, but should be considered alongside other market data and company news.

Stakeholder Impact

• The stock purchase could positively influence shareholder sentiment.

Key Dates